Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129